Modified hTERT Promoters-Driven Purine Nucleoside Phosphorylase-Gene Therapy in Association with chemo- and Targeted Therapy in the Context of Ovarian Cancer

Researchers proposed an original ovarian cancer treatment through the use of two recently developed modified hTERT promoters: the mutated hTERT and the chimeric hTERT-CMV.